TITLE

Eureka!

AUTHOR(S)
Kaelbe, Steve
PUB. DATE
August 2002
SOURCE
Indiana Business Magazine;Aug2002, Vol. 46 Issue 8, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the discovery of folate as a cure for cancer by Endocyte, a biotechnology firm in Lafayette, Indiana. Study made by Chris Leamon, vice president of the company, and colleagues regarding folate; Benefits of connecting folate to diagnostic imaging agent; Process of developing a diagnostic product called FolateScan.
ACCESSION #
7226733

 

Related Articles

  • Small Molecule Drug Conjugates for Personalized Cancer Therapy. Leamon, Christopher P. // Drug Discovery & Development;Jun2011 Supplement, Vol. 14, p17 

    The article reports on the plan of Endocyte Inc. to develop small-molecule drug conjugates (SMDC) for the treatment of cancer. The research and development (R&D) group of Endocyte stays focused on producing a rich pipeline of targeted drug molecule with different mechanisms of action. Endocyte...

  • Endocyte's potential enthralls investors. O'Malley, Chris // Indianapolis Business Journal;5/9/2011, Vol. 32 Issue 10, p1A 

    The article reports on the Lafayette, Indiana-based biotechnology firm Endocyte Inc.'s doubled shares from initial offering in February 2011 despite the forecast that it will not meet sales from its cancer drug up to 2014. The firm's chief executive officer (CEO), Ron Ellis, says that the...

  • Endocyte leads VC pack. Schnitzler, Peter // Indianapolis Business Journal;3/22/2004, Vol. 25 Issue 2, p19 

    Reports that West Lafayette-based biotechnology firm Endocyte Inc. leads venture capital deals in Indiana. Grant money received from the Indiana 21st Century Research and Technology Fund; Endocyte's opportunity for economic growth; Factors that gave the company's confidence to invest.

  • CLINIC ROUNDUP.  // BioWorld Today;8/11/2009, Vol. 20 Issue 153, p6 

    This section offers news briefs on clinical trials in the biotechnology industry. A trial by Eiger BioPharmaceuticals Inc. will investigate the antiviral effect of clemizole monotherapy in the absence of interferon. The trial conducted by Endocyte Inc. on EC145 in advanced non-small-cell lung...

  • COMMON VITAMIN MAY HELP DETECT OVARIAN CANCER.  // Medical Update;Mar2001, Vol. 24 Issue 9, p2 

    Offers information about FolateScan, a procedure for detecting ovarian cancer using folic acid.

  • Fighting Cancer With Folate.  // Medical Update;Jul2002, Vol. 28 Issue 1, p1 

    Discusses the findings of a study on the therapeutic effects of folate on cancer.

  • Increased uracil misincorporation in lymphocytes from folate-deficient rats. Duthie, S J; Grant, G; Narayanan, S // British Journal of Cancer;12/1/2000, Vol. 83 Issue 11, p1532 

    The development of certain human cancers has been linked with inadequate intake of folates. The effects of folate deficiency in vivo on DNA stability (strand breakage, misincorporated uracil and oxidative base damage) in lymphocytes isolated from rats fed a diet deficient in folic acid was...

  • Supplementation with folic acid did not affect cancer incidence.  // Hem/Onc Today;5/10/2013, Vol. 14 Issue 9, p8 

    The article presents information on research which assessed the relations of folic acid supplementation with cancer incidence.

  • Life-Science Breakthroughs. McKimmie, Kathy // Indiana Business Magazine;Sep2005, Vol. 49 Issue 9, p26 

    Reports on life sciences innovations from various Indiana companies. Food and Drug Administration's approval of Roche Diagnostics Corp.'s AmpliChip Test which allows physicians to consider a patient's genetic information in selecting medications and doses for a variety of conditions; Endocyte...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics